Piroxicam
CAS 36322-90-4
Overview
Piroxicam is a nonsteroidal anti-inflammatory drug of the oxicam class used to relieve the symptoms of painful inflammatory conditions like arthritis. Piroxicam works by preventing the production of endogenous prostaglandins which are involved in the mediation of pain, stiffness, tenderness and swelling
Anant Labs manufacture and furnish high quality Piroxicam impurities for global markets. Our Piroxicam EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS36322-90-4
Mol. FormulaC15H13N3O4S
Mol. Weight331.353 g/mol
IUPAC4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide
SMILESCN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3
InChIInChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)
InChI KeyQYSPLQLAKJAUJT-UHFFFAOYSA-N
Synonyms
piroxicam36322-90-4FeldenePiroxicamumPyroxycamRoxicamBAXOPiroftalCP-16171LarapamCP 161712H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxideCHF 1251DTXSID502117013T4O6VMAMNSC-666076CHEBI:8249CP-16,1714-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxidNSC666076DTXCID4011704-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxideCP16171FlamatrolKenteneFeldene p4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l^(6),2-benzothiazine-3-carboxamide4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l^{6},2-benzothiazine-3-carboxamidePiroflam 10Piroflam 20Feldene 20Pirozip 10Pirozip 20RefChem:6147M01AC01M02AA07S01BC064-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboximide-1,1-dioxide252-974-3Brexidol4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxideArtroxicamC15H13N3O4SNSC 6660764-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxideMFCD000573174-Hydroxy-2-methyl-3-(pyrid-2-yl-carbamoyl)-2H-1,2-benzothiazine 1,1-dioxide4-Hydroxy-2-methyl-N-2-pyridyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxideMLS0000696441044566-76-84-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide2H-1,2-Benzothiazine-3-carboxamide,4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxideNCGC00015823-02BruxicamCalimentFlogobeneGeldeneImprontalPiroflexReudeneRoxidenSasulenSMR000035997SolocalmErazonPirkamRiacenZundenRoxamCAS-36322-90-4Piroxicamum [INN-Latin](3Z)-3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trioneRosidenFeldenFeldene FastFeldene Gel(4-hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamid e4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-DioxideFeldene (TN)Piroxicam (Feldene)CCRIS 3719SR-01000000199EINECS 252-974-3AK1015UNII-13T4O6VMAMBRN 0627692Flamatrol;Improntal;Cycladol;Piroflam;Larapam;Pirozip;Reudene;Brexin;Piroxicam CRSFasax;Pirox;Prestwick_5734-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid [German]Piroxicam (Standard)Piroxicam [USAN:USP:INN:BAN:JAN]piroxicam:malonic acidSpectrum_001115Tocris-0960Opera_ID_442PIROXICAM [INN]PIROXICAM [JAN]Piroxicam: Form Alpha1Piroxicam: Form Alpha2PIROXICAM [MI]PIROXICAM [USAN]Prestwick0_000211Prestwick1_000211Prestwick2_000211Prestwick3_000211Spectrum2_001287Spectrum3_000780Spectrum4_000968Spectrum5_001445Lopac-P-5654PIROXICAM [VANDF]PIROXICAM ANHYDROUSCHEMBL527Epitope ID:613453PIROXICAM [MART.]P 5654PIROXICAM [USP-RS]PIROXICAM [WHO-DD]BIDD:PXR0154Lopac0_000900Oprea1_714707SCHEMBL13462SCHEMBL21350BSPBio_000221BSPBio_001030BSPBio_002460KBioGR_000370KBioGR_001315KBioSS_000370KBioSS_001595MLS000038002MLS001148207MLS001304054MLS004774122DivK1c_000369SPECTRUM1500491SPBio_001293SPBio_002142Piroxicam (JP18/USP/INN)BPBio1_000245GTPL7273orb1310318Piroxicam, >=98% (TLC)SCHEMBL3703617PIROXICAM [ORANGE BOOK]Piroxicam for system suitabilityCHEMBL1518938PIROXICAM [EP MONOGRAPH]SCHEMBL29352427SCHEMBL29396075BCBcMAP01_000176BDBM85245HMS501C11HY-B0253RKBio1_000369KBio2_000370KBio2_001595KBio2_002938KBio2_004163KBio2_005506KBio2_006731KBio3_000719KBio3_000720KBio3_001680MSK7162PIROXICAM [USP MONOGRAPH]NINDS_000369Piroxicam 1.0 mg/ml in MethanolBio1_000363Bio1_000852Bio1_001341Bio2_000355Bio2_000835GLXC-26155GLXC-26156HMS1362D11HMS1568L03HMS1792D11HMS1920H22HMS1990D11HMS2089B06HMS2092A05HMS2095L03HMS2231G03HMS3262D22HMS3267I03HMS3369B07HMS3403D11HMS3414H17HMS3429L03HMS3655C04HMS3678H15HMS3712L03HMS3884C08HMS5079F16Pharmakon1600-01500491HY-B0253NSC_4856Tox21_110231Tox21_200151Tox21_500900BBL016493CCG-36403EBC-11158EBC-26614MSK7162-100ANSC757284Piroxicam for system suitability CRSs1713STK177288AKOS000714958AKOS025312555AKOS026749939MSK7162-1000ATox21_110231_1DB00554FP27085KS-5322LP00900NSC-757284SDCCGSBI-0050875.P005(4-Hydroxy-2-methyl-1,1-dioxobenzo[e]1,2-thiazin-3-yl)-N-(2-pyridyl)carboxamide4-hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxideIDI1_000369IDI1_002110NCGC00015823-01NCGC00015823-03NCGC00015823-04NCGC00015823-05NCGC00015823-06NCGC00015823-07NCGC00015823-08NCGC00015823-09NCGC00015823-10NCGC00015823-11NCGC00015823-12NCGC00015823-13NCGC00015823-14NCGC00015823-15NCGC00015823-17NCGC00015823-18NCGC00015823-20NCGC00015823-29NCGC00021244-03NCGC00021244-05NCGC00021244-06NCGC00021244-07NCGC00021244-08NCGC00021244-09NCGC00188982-01NCGC00257705-01NCGC00261585-01(Z)-3-(hydroxy(pyridin-2-ylamino)methylene)-2-methyl-2H-benzo[e][1,2]thiazin-4(3H)-one 1,1-dioxideAC-24190NCI60_022912ST069379SBI-0050875.P004CAS_36322-90-4Piroxicam, meets USP testing specificationsEU-0100900NS00015466P1905P3269SW219862-1EN300-70724Piroxicam Solution in Acetonitrile, 100ug/mLC01608D00127D70554Piroxicam Solution in Acetonitrile, 1000ug/mLAB00052074-21AB00052074-22AB00052074_23AB00052074_24F340495Q408676SR-01000000199-3SR-01000000199-5SR-01000000199-9SR-01000000199-12F0001-2399Piroxicam, British Pharmacopoeia (BP) Reference StandardZ1137167677Piroxicam, European Pharmacopoeia (EP) Reference StandardPiroxicam, United States Pharmacopeia (USP) Reference StandardPiroxicam, Pharmaceutical Secondary Standard; Certified Reference Material4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1$l^{6},2-benzothiazine-3-carboxamide4-hydroxy-2-methyl-1,1-dioxo-N-(2-pyridyl)-1lambda6,2-benzothiazine-3-carboxamide4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-2H-1,2-benzothiazine 1,1-Dioxide4-Hydroxy-2-methyl-N-(pyridin-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide1,1-dioxide4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboxamide1,1-dioxideN-(2-pyridyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide3-(Hydroxy[(pyridin-2-yl)amino]methylidene)-2-methyl-3,4-dihydro-2h-1lambda(6),2-benzothiazine-1,1,4-trione3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1$l^{6},2-benzothiazine-1,1,4-trione3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione4-Hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-1,2-dihydro-1lambda~6~,2-benzothiazine-3-carboxamide4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazine -3-carboxamide-1,1-dioxide malonic acid